Matsumoto S, Takahashi T, Tanimoto T, Saiki C, Takeda M
Department of Physiology, Nippon Dental University, School of Dentistry at Tokyo, Tokyo, Japan.
J Pharmacol Exp Ther. 1999 Sep;290(3):974-9.
In anesthetized, artificially ventilated rabbits with vagus nerve section, inhalation of CO(2) gas mixtures (tracheal CO(2) concentration ranging from 8.0 to 10.2%) for 60 s decreased slowly adapting pulmonary stretch receptor (SAR) activity during both inflation and deflation. The magnitude of decreased receptor activity during deflation had a more pronounced effect than that seen during inflation. CO(2) inhalation did not cause any significant change in tracheal pressure (P(T)) as an index of bronchomotor tone. Intravenous administration of 4-aminopyridine (0. 7 and 2.0 mg/kg i.v.), a K(+) channel blocker, which dose-dependently increased SAR activity during deflation and had no effect on P(T), abolished or attenuated the decrease in SAR activities induced by CO(2) inhalation in a dose-dependent manner. The K(+) channel blocker tetraethylammonium (2.0 and 6.0 mg/kg i.v.) that did not significantly alter either basal SAR discharge or P(T) had no effect on the inhibitory responses of receptor activity to CO(2) inhalation. These results suggest that the inhibitory mechanism of CO(2) inhalation on SARs may be involved in the activation of 4-aminopyridine-sensitive K(+) channels in the nerve terminals of SARs.
在切断迷走神经的麻醉、人工通气兔中,吸入CO₂混合气体(气管CO₂浓度为8.0%至10.2%)60秒,在充气和放气过程中均降低了慢适应性肺牵张感受器(SAR)的活动。放气过程中感受器活动降低的幅度比充气过程中更为明显。吸入CO₂作为支气管运动张力指标的气管压力(P(T))未引起任何显著变化。静脉注射钾通道阻滞剂4-氨基吡啶(0.7和2.0毫克/千克静脉注射),其在放气过程中剂量依赖性地增加SAR活动且对P(T)无影响,以剂量依赖性方式消除或减弱了吸入CO₂诱导的SAR活动降低。钾通道阻滞剂四乙铵(2.0和6.0毫克/千克静脉注射)对基础SAR放电或P(T)均无显著改变,对感受器活动对吸入CO₂的抑制反应也无影响。这些结果表明,吸入CO₂对SAR的抑制机制可能与SAR神经末梢中4-氨基吡啶敏感的钾通道激活有关。